Microbiology

  1. Risk factors associated with mortality in hospitalized patients with SARS-CoV-2 infection. A prospective, longitudinal, unicenter study in Reus, Spain

    1. Simona Iftimie
    2. Ana F. López-Azcona
    3. Manuel Vicente-Miralles
    4. Ramon Descarrega-Reina
    5. Anna Hernández-Aguilera
    6. Francesc Riu
    7. Josep M. Simó
    8. Pedro Garrido
    9. Jorge Joven
    10. Jordi Camps
    11. Antoni Castro

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  2. Optimized Pseudotyping Conditions for the SARS-COV-2 Spike Glycoprotein

    1. Marc C. Johnson
    2. Terri D. Lyddon
    3. Reinier Suarez
    4. Braxton Salcedo
    5. Mary LePique
    6. Maddie Graham
    7. Clifton Ricana
    8. Carolyn Robinson
    9. Detlef G. Ritter

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  3. Naturally occurring SARS-CoV-2 gene deletions close to the spike S1/S2 cleavage site in the viral quasispecies of COVID19 patients

    1. Cristina Andres
    2. Damir Garcia-Cehic
    3. Josep Gregori
    4. Maria Piñana
    5. Francisco Rodriguez-Frias
    6. Mercedes Guerrero-Murillo
    7. Juliana Esperalba
    8. Ariadna Rando
    9. Lidia Goterris
    10. Maria Gema Codina
    11. Susanna Quer
    12. Maria Carmen Martín
    13. Magda Campins
    14. Ricard Ferrer
    15. Benito Almirante
    16. Juan Ignacio Esteban
    17. Tomás Pumarola
    18. Andrés Antón
    19. Josep Quer

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  4. An alpaca nanobody neutralizes SARS-CoV-2 by blocking receptor interaction

    1. Leo Hanke
    2. Laura Vidakovics Perez
    3. Daniel J. Sheward
    4. Hrishikesh Das
    5. Tim Schulte
    6. Ainhoa Moliner-Morro
    7. Martin Corcoran
    8. Adnane Achour
    9. Gunilla B. Karlsson Hedestam
    10. B. Martin Hällberg
    11. Ben Murrell
    12. Gerald M. McInerney

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  5. A Scalable Topical Vectored Vaccine Candidate against SARS-CoV-2

    1. Mohammed A. Rohaim
    2. Muhammad Munir

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  6. Dose-dependent response to infection with SARS-CoV-2 in the ferret model and evidence of protective immunity

    1. Kathryn A. Ryan
    2. Kevin R. Bewley
    3. Susan A. Fotheringham
    4. Gillian S. Slack
    5. Phillip Brown
    6. Yper Hall
    7. Nadina I. Wand
    8. Anthony C. Marriott
    9. Breeze E. Cavell
    10. Julia A. Tree
    11. Lauren Allen
    12. Marilyn J. Aram
    13. Thomas J. Bean
    14. Emily Brunt
    15. Karen R. Buttigieg
    16. Daniel P. Carter
    17. Rebecca Cobb
    18. Naomi S. Coombes
    19. Steve J. Findlay-Wilson
    20. Kerry J. Godwin
    21. Karen E. Gooch
    22. Jade Gouriet
    23. Rachel Halkerston
    24. Debbie J. Harris
    25. Thomas H. Hender
    26. Holly E. Humphries
    27. Laura Hunter
    28. Catherine M. K. Ho
    29. Chelsea L. Kennard
    30. Stephanie Leung
    31. Stephanie Longet
    32. Didier Ngabo
    33. Karen L. Osman
    34. Jemma Paterson
    35. Elizabeth J. Penn
    36. Steven T. Pullan
    37. Emma Rayner
    38. Oliver Skinner
    39. Kimberley Steeds
    40. Irene Taylor
    41. Tom Tipton
    42. Stephen Thomas
    43. Carrie Turner
    44. Robert J. Watson
    45. Nathan R. Wiblin
    46. Sue Charlton
    47. Bassam Hallis
    48. Julian A. Hiscox
    49. Simon Funnell
    50. Mike J. Dennis
    51. Catherine J. Whittaker
    52. Michael G. Catton
    53. Julian Druce
    54. Francisco J. Salguero
    55. Miles W. Carroll

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  7. Experimental infection of domestic dogs and cats with SARS-CoV-2: Pathogenesis, transmission, and response to reexposure in cats

    1. Angela M. Bosco-Lauth
    2. Airn E. Hartwig
    3. Stephanie M. Porter
    4. Paul W. Gordy
    5. Mary Nehring
    6. Alex D. Byas
    7. Sue VandeWoude
    8. Izabela K. Ragan
    9. Rachel M. Maison
    10. Richard A. Bowen

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  8. Structure-based design of prefusion-stabilized SARS-CoV-2 spikes

    1. Ching-Lin Hsieh
    2. Jory A. Goldsmith
    3. Jeffrey M. Schaub
    4. Andrea M. DiVenere
    5. Hung-Che Kuo
    6. Kamyab Javanmardi
    7. Kevin C. Le
    8. Daniel Wrapp
    9. Alison G. Lee
    10. Yutong Liu
    11. Chia-Wei Chou
    12. Patrick O. Byrne
    13. Christy K. Hjorth
    14. Nicole V. Johnson
    15. John Ludes-Meyers
    16. Annalee W. Nguyen
    17. Juyeon Park
    18. Nianshuang Wang
    19. Dzifa Amengor
    20. Jason J. Lavinder
    21. Gregory C. Ippolito
    22. Jennifer A. Maynard
    23. Ilya J. Finkelstein
    24. Jason S. McLellan

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  9. Head-to-head comparison of four antigen-based rapid detection tests for the diagnosis of SARS-CoV-2 in respiratory samples

    1. Thomas Weitzel
    2. Paulette Legarraga
    3. Mirentxu Iruretagoyena
    4. Gabriel Pizarro
    5. Valeska Vollrath
    6. Rafael Araos
    7. José M. Munita
    8. Lorena Porte

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  10. Efficacy of a novel SARS-CoV-2 detection kit without RNA extraction and purification

    1. Tatsuya Fukumoto
    2. Sumio Iwasaki
    3. Shinichi Fujisawa
    4. Kasumi Hayasaka
    5. Kaori Sato
    6. Satoshi Oguri
    7. Keisuke Taki
    8. Sho Nakakubo
    9. Keisuke Kamada
    10. Yu Yamashita
    11. Satoshi Konno
    12. Mutsumi Nishida
    13. Junichi Sugita
    14. Takanori Teshima

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity
Previous Page 55 of 246 Next